{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12086983", "DateCompleted": {"Year": "2002", "Month": "12", "Day": "23"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "11"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0007-1188", "JournalIssue": {"Volume": "136", "Issue": "5", "PubDate": {"Year": "2002", "Month": "Jul"}}, "Title": "British journal of pharmacology", "ISOAbbreviation": "Br J Pharmacol"}, "ArticleTitle": "Airway function, oedema, cell infiltration and nitric oxide generation in conscious ozone-exposed guinea-pigs: effects of dexamethasone and rolipram.", "Pagination": {"StartPage": "735", "EndPage": "745", "MedlinePgn": "735-45"}, "Abstract": {"AbstractText": ["1. The effects of ozone inhalation (90 min, 2.15+/-0.05 p.p.m.) and their modification by dexamethasone (20 mg kg(-1)) or the phosphodiesterase-4 inhibitor, rolipram (1 mg kg(-1)), administered (i.p.) 24 and 0.5 h before and 24 h after ozone exposure were examined in conscious guinea-pigs. 2. Ozone caused an early-phase bronchoconstriction (EPB) as a fall in specific airways conductance (sG(aw)) measured by whole body plethysmography, followed at 5 h by a late-phase bronchoconstriction (LPB) and increased respiratory rate. Rolipram did not alter this profile but dexamethasone inhibited the EPB. 3. Airway hyperreactivity to inhaled histamine (1 mM, 20 s) occurred at 0.5, 2, 12, 24 and 48 h after ozone inhalation, the 2 h change being abolished by rolipram and dexamethasone. 4. Bronchoalveolar lavage fluid (BALF) macrophages, eosinophils and neutrophils were significantly (P<0.05) elevated at 12, 24 and 48 h after ozone exposure, the 48 h influx being significantly attenuated (P<0.05) by rolipram and dexamethasone. 5. BALF nitric oxide (NO) metabolites decreased 0.5 h after ozone exposure by 52%, recovered at 2 h and significantly increased at 12 (101%) and 24 h (127%). The elevated NO was unaffected by rolipram or dexamethasone. 6. Lung oedema, measured from wet/dry weight differences, was significant 12, 24 and 48 h after ozone exposure, the latter being significantly attenuated (P<0.05) by rolipram and dexamethasone. 7. Ozone exposure of guinea-pigs produced features common to COPD. Although rolipram and dexamethasone did not affect the airway function changes, they inhibited the inflammation, airway hyperreactivity and oedema."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cathays Park, Cardiff CF10 3XF."}], "Identifier": [], "LastName": "Toward", "ForeName": "Toby J", "Initials": "TJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Broadley", "ForeName": "Kenneth J", "Initials": "KJ"}], "GrantList": [{"Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Br J Pharmacol", "NlmUniqueID": "7502536", "ISSNLinking": "0007-1188"}, "ChemicalList": [{"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7S5I7G3JQL", "NameOfSubstance": "Dexamethasone"}, {"RegistryNumber": "K676NL63N7", "NameOfSubstance": "Rolipram"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Dexamethasone"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Neutrophil Infiltration"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Pulmonary Disease, Chronic Obstructive"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Pulmonary Edema"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Rolipram"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "AGUSTI A.G.N., VILAVERDE J.M., TOGORES B., BOSCH M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 1999;14:523\u2013528.", "ArticleIdList": ["10543270"]}, {"Citation": "ALVING K., WEITZBERG E., LUNDBERG J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 1993;6:1368\u20131370.", "ArticleIdList": ["7507065"]}, {"Citation": "ARAKIDA Y., OHGA K., SUWA K., OKADA Y., MORIO H., YOKOTA M., MIYATA K., YAMADA T., HONDA K. Effect of YM158, a dual lipid mediator antagonist, on immediate and late asthmatic responses, and on airway hyper-responsiveness in guinea pigs. Jpn. J. Pharmacol. 2000;82:287\u2013294.", "ArticleIdList": ["10875747"]}, {"Citation": "ARIS R.M., CHRISTIAN D., HEARNE P.Q., KERR K., FINKBEINER W.E., BALMES J.R. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 1993;148:1363\u20131372.", "ArticleIdList": ["8239177"]}, {"Citation": "BARNES P.J, , CHUNG K.F, PAGE C.P. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1999;50:515\u2013575.", "ArticleIdList": ["9860804"]}, {"Citation": "BARNES P.J., ADCOCK I.M. NF-\u03baB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997;18:46\u201351.", "ArticleIdList": ["9090308"]}, {"Citation": "BHOWMIK A., SEEUNGAL T., ROLAND M., WEDZICHA J.A. Exhaled nitric oxide in patients with COPD. Proceedings from the British Thoracic Society winter meeting. Thorax. 1998;53:158P."}, {"Citation": "BOUSQUET J., JEFFERY P., BUSSE W.W., JOHNSON M., VIGNOLA A.M. Asthma: from bronchoconstriction to airway inflammation and remodelling. Am. J. Respir. Crit. Care Med. 2000;161:1720\u20131745.", "ArticleIdList": ["10806180"]}, {"Citation": "BURGE P.S. Editorial: EUROSCOP, ISOLDE and the Copenhagen City Lung Study. Thorax. 1999;54:287\u2013288.", "ArticleIdList": ["PMC1745471", "10092687"]}, {"Citation": "CALVERLEY P.M.A. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000;161:341\u2013342.", "ArticleIdList": ["10673165"]}, {"Citation": "CARDILE V., JIANG X., RUSSO A., CASELLA F., RENIS M., BINDONI M. Effects of ozone on some biological activities of cells in vitro. Cell Biol. Tox. 1995;11:11\u201321.", "ArticleIdList": ["7600255"]}, {"Citation": "COLASANTI M., SUZUKI H. The dual personality of NO. Trends Pharmacol. Sci. 2000;21:249\u2013252.", "ArticleIdList": ["10979862"]}, {"Citation": "CORRADI M., MAGATI M., CACCIANI G.C., CONSIGLI G.F., DE MUNARI E., PESCI A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax. 1999;54:572\u2013575.", "ArticleIdList": ["PMC1745512", "10377199"]}, {"Citation": "DANAHAY H., BROADLEY K.J. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitised guinea-pigs and airway leukocyte infiltration. Br. J. Pharmacol. 1997;120:289\u2013297.", "ArticleIdList": ["PMC1564374", "9117122"]}, {"Citation": "FINNEY M.J., FORSBERG K.J. Quantification of nasal involvement in a guinea-pig plethysmography. J. App. Physiol. 1994;76:1432\u20131438.", "ArticleIdList": ["8045816"]}, {"Citation": "GIAID A., SALEH D., LIM S., BARNES P.J., ERNST P. Formation of peroxynitrite in asthmatic airways. FASEB. J. 1998;12:929\u2013937.", "ArticleIdList": ["9707165"]}, {"Citation": "GORDON T., TAYLOR B.F., AMDUR M.O. Ozone inhibition of tissue cholinesterase in gunea-pigs. Arch. Envriron. Health. 1981;36:284\u2013288.", "ArticleIdList": ["7316565"]}, {"Citation": "GRIFFITHS-JOHNSON D.A., NICHOLLS P.J., MCDERMOTT M. Measurement of specific airways conductance in guinea-pigs: A non-invasive method. J. Pharmacol. Meth. 1988;19:233\u2013242.", "ArticleIdList": ["3393005"]}, {"Citation": "GRISHAM M.B., JOHNSON G.G., LANCASTER J.R. Quantification of nitrate and nitrite in extracellular fluids. Meth. Enzymology. 1996;268:237\u2013246.", "ArticleIdList": ["8782590"]}, {"Citation": "HADDAD E.B., LIU S.F., SALMON M., ROBICHAUD A., BARNES P.J., CHUNG K.F. Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. Eur. J. Pharmacol. 1995;293:287\u2013290.", "ArticleIdList": ["8666049"]}, {"Citation": "HAZUCHA M.J. Relationship between ozone exposure and pulmonary function changes. J. Appl. Physiol. 1987;62:1671\u20131680.", "ArticleIdList": ["3298195"]}, {"Citation": "HOLBROOK M., GOZZARD N., JAMES T., HIGGS G., HUGHES B. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br. J. Pharmacol. 1996;118:1192\u20132000.", "ArticleIdList": ["PMC1909603", "8818343"]}, {"Citation": "HWANG Y.S., LEFFERTS P.L, SNAPPER J.R. Correlation between increased airway responsiveness and severity of pulmonary oedema. Pulmon. Pharmacol. Ther. 2001;14:47\u201353.", "ArticleIdList": ["11162419"]}, {"Citation": "ICHINOSE M., SUGIURA H., YAMAGATA S., KOARAI A., SHIRATO K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am. J. Respir. Crit. Care Med. 2000;162:701\u2013706.", "ArticleIdList": ["10934109"]}, {"Citation": "IGARASHI A., IIJIMA H., TAMURA G., SHIRATO K. Tazanolast inhibits ozone-induced airway hyperresponsiveness in guinea pigs. Am. J. Respir. Crit. Care Med. 1998;157:1531\u20131535.", "ArticleIdList": ["9603134"]}, {"Citation": "INOUE H., AIZAWA H., NAKANO H., MATSUMOTO K., KUWANO K., NADEL J.A., HARA N. Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am. J. Respir. Crit. Care Med. 2000;161:249\u2013258.", "ArticleIdList": ["10619828"]}, {"Citation": "JACOBY D.B., COSTELLO R.M., FRYER A.D. Eosinophil recruitment to the airway nerves. J. Allergy Clin. Immunol. 2001;107:211\u2013218.", "ArticleIdList": ["11174183"]}, {"Citation": "JOAD J.P., MCDONALD R.J. , GIRI S.N., BRIC J.M. Ozone effects on mechanics and arachadonic acid metabolite concentrations in isolated rat lungs. Environmental Research. 1994;66:186\u2013197.", "ArticleIdList": ["8055840"]}, {"Citation": "JOHNSON A., LEWIS C.A., BROADLEY K.J. Effects of low-level ozone exposure on reactivity and conductance in guinea pig airways. Inhalation Toxicol. 1998;10:101\u2013118."}, {"Citation": "MOTULSKY H. Intuitive Biostatistics. Oxford: Oxford University Press; 1995. Common and advanced statistical tests; pp. 207\u2013284."}, {"Citation": "MURLAS C.G., LANG Z., CHODIMELLA V. Dexamethasone reduces tachykinin but not ACh airway hyperreactivity after O3. Lung. 1993;171:109\u2013121.", "ArticleIdList": ["7678875"]}, {"Citation": "MURLAS C.G., ROUM J.H. Sequence of pathologic changes in the airway mucosa of guinea pigs during ozone-induced bronchial hyperreactivity. Am. Rev. Respir. Dis. 1985;131:314\u2013320.", "ArticleIdList": ["3977170"]}, {"Citation": "NAKANO H., AIZAWA H., MATSUMOTO K., FUKUYAMA S., INOUE H., HARA N. Cyclooxygenase-2 participates in the late phase of airway hyperresponsiveness after ozone exposure in guinea pigs. Eur. J. Pharmacol. 2000;403:267\u2013275.", "ArticleIdList": ["10973629"]}, {"Citation": "NIJKAMP F.P., FOLKERTS G. Nitric oxide and bronchial hyperresponsiveness. Arch. Int. Pharmacodyn. 1995;329:97\u2013110.", "ArticleIdList": ["7639622"]}, {"Citation": "PARE P.D., HOGG J.C. Mechanics of airway narrowing. Am. Rev. Respir. Dis. 1989;139:242\u2013246.", "ArticleIdList": ["2912345"]}, {"Citation": "POSTMA D.S., KERSTJENS H.A.M. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998;158:S187\u2013S192.", "ArticleIdList": ["9817744"]}, {"Citation": "REPINE J.E., BAST A, , LANKHORST I., THE OXIDATIVE STRESS STUDY GROUP Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997;156:341\u2013357.", "ArticleIdList": ["9279209"]}, {"Citation": "SALEH D., ERNST P., LIM S., BARNES P., GIAID A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticosteroids. FASEB J. 1998;12:929\u2013937.", "ArticleIdList": ["9707165"]}, {"Citation": "SCHULTHEIS A.H., BASSETT D.J.P., FRYER A.D. Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function. J. Appl. Physiol. 1994;76:1088\u20131097.", "ArticleIdList": ["8005850"]}, {"Citation": "SELTZER J., BIGBY B.G., STULBARG M., HOLTZMAN M.J., NADEL J.A, , UEKI I.F., LEIKAUF G.D., GOETZL E.J, BOUSHEY H.A. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 1986;60:1321\u20131326.", "ArticleIdList": ["3084448"]}, {"Citation": "SPINA D., SHAH S., HARRISON S. Modulation of sensory nerve function in the airways. Trends Pharmacol. Sci. 1998;19:460\u2013465.", "ArticleIdList": ["9850610"]}, {"Citation": "STAUB N.C., SrThe respiratory System Physiology 1993London: Mosby Year Book Press; 547\u2013599.3. ed. Berne, R.M., Levy, M.N., pp"}, {"Citation": "STOCKLEY R.A.Biochemical and cellular mechanisms Chronic Obstructive Pulmonary Disease 1995London: Chapman & Hall Medical Press; 93\u2013135.1. ed. Calverley, P.M.A., Pride, N., pp"}, {"Citation": "TORPHY T.J., BARNETTE M.S., UNDERWOOD D.C., GRISWOLD D.E., CHRISTENSEN S.B., MURDOCH R.D., NIEMAN R.B., COMPTON C.H. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulmonary Pharmacol. Ther. 1999;12:131\u2013135.", "ArticleIdList": ["10373396"]}, {"Citation": "TOWARD T.J., BROADLEY K.J. Early and late phase bronchoconstrictions, airway hyperreactivity, cell influx and steroid- or rolipram-sensitivity, after inhaled ozone, in conscious guinea-pigs. Br. J. Pharmacol. 2000a;131:113P."}, {"Citation": "TOWARD T.J., BROADLEY K.J. Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation. Br. J. Pharmacol. 2000b;131:271\u2013281.", "ArticleIdList": ["PMC1572332", "10991920"]}, {"Citation": "TOWARD T.J., BROADLEY K.J. Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea-pigs: Effects of rolipram and dexamethasone. J.Pharmacol.Exp.Ther. 2001a;298:298\u2013306.", "ArticleIdList": ["11408555"]}, {"Citation": "TOWARD T.J., BROADLEY K.J. Airway function, hyperreactivity, cell influx and nitric oxide, in conscious parainfluenza-3 virus infected guinea-pigs: Effects of rolipram and dexamethasone. Br. J. Pharmacol. 2001b;135:70P."}, {"Citation": "VRUGT B., AALBERS R. Inflammation and bronchial hyperresponsiveness in allergic asthma and chronic obstructive pulmonary disease. Respir. Med. 1993;87:B3\u2013B7.", "ArticleIdList": ["8234965"]}]}], "History": [{"Year": "2002", "Month": "6", "Day": "28", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "12", "Day": "27", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "6", "Day": "28", "Hour": "10", "Minute": "0"}, {"Year": "2003", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12086983", "PMC1573394", "10.1038/sj.bjp.0704764", "0704764"]}}], "PubmedBookArticle": []}